论文信息 - Expression of E-cadherin and KRAS mutation may serve as biomarkers of cetuximab-based therapy in metastatic colorectal cancer - 字舞流文

Expression of E-cadherin and KRAS mutation may serve as biomarkers of cetuximab-based therapy in metastatic colorectal cancer

M. Yashiro | K. Hirakawa | K. Maeda | M. Ohira | Y. Nishiguchi | H. Nagahara | K. Nakamoto | Toru Inoue | E. Noda | Eiji Noda